Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–8 of 8 results
Advanced filters: Author: Gil Arbel Clear advanced filters

  • Effectiveness of one subcutaneous dose of MVA-BN, the smallpox and mpox vaccine, was estimated to be 86% in a cohort of vaccine-eligible males in Israel, supporting its use to curtail the outbreak of mpox virus.

    • Yael Wolff Sagy
    • Roy Zucker
    • Doron Netzer
    Research
    Nature Medicine
    Volume: 29, P: 748-752

  • Quasi-phase matching enhances nonlinear optics but typically requires fixed material changes. Here, authors demonstrate the first optically programmable quasi-phase matching in standard fibers, enabling broadband, tunable wavelength conversion over 298 nm without altering the fiber.

    • Gil Bashan
    • Avishay Eyal
    • Ady Arie
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-9

  • Here authors reveal a method to predict key information on phenotypes - their direction. This is achievable even for phenotypes with incomplete genotype-to-phenotype mapping, and applicable for individuals from the same family or population, as well as between species.

    • David Gokhman
    • Keith D. Harris
    • Gili Greenbaum
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-11

  • In a retrospective study of individuals living with diabetes and obesity, conducted from 2008 through 2021, treatment with bariatric metabolic surgery was more effective than treatment with GLP-1 receptor agonists for prevention of incident congestive heart failure.

    • Yael Wolff Sagy
    • Gil Lavie
    • Dror Dicker
    Research
    Nature Medicine
    Volume: 30, P: 2337-2342

  • Long QT syndrome (LQTS) is a life-threatening congenital arrhythmogenic disease. This study models type-2 LQTS, which is caused by a mutation in the potassium-channel-encoding KCNH2 gene, by using induced pluripotent stem cell technology to generate cardiomyocytes from the fibroblasts of an individual diagnosed with the syndrome. The cells were used to screen a variety of drugs for either amelioration or aggravation of the disease phenotype, demonstrating the power of this approach for drug development and for patient-specific safety screening.

    • Ilanit Itzhaki
    • Leonid Maizels
    • Lior Gepstein
    Research
    Nature
    Volume: 471, P: 225-229